Lineage Cell Therapeutics, Inc.
US ˙ NYSEAM ˙ US53566P1093

SecurityLCTX / Lineage Cell Therapeutics, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in LCTX / Lineage Cell Therapeutics, Inc.

On May 13, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Lineage Cell Therapeutics, Inc. (US:LCTX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 6,503 shares of Lineage Cell Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (LCTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

LCTX / Lineage Cell Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 0 -6,503 -100.00 0 -100.00
2026-02-11 2025-12-31 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 6,503 6,503 11 0.0000
2025-05-14 2024-12-31 13F/A-1 LINEAGE CELL THERAPEUTICS IN COM 53566P109 0 -745 -100.00 0 0.0000
2025-02-14 2024-12-31 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 0 -745 0 0.0000
2024-11-14 2024-09-30 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 745 745 1 0.0000
2023-11-09 2023-09-30 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 0 -972 -100.00 0 -100.00
2023-08-09 2023-06-30 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 972 0 0.00 1 0.00 0.0000
2023-05-12 2023-03-31 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 972 972 1 0.0000
2022-02-11 2021-12-31 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 0 -13,807 -100.00 0 -100.00
2021-11-12 2021-09-30 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 13,807 13,807 35 0.0000
2021-02-10 2020-12-31 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 0 -10,279 -100.00 0 -100.00
2020-11-12 2020-09-30 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 10,279 0 0.00 10 11.11 0.0000
2020-08-13 2020-06-30 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 10,279 0 0.00 9 0.00 0.0000
2020-05-13 2020-03-31 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 10,279 -6,900 -40.17 9 -40.00 0.0001
2020-02-10 2019-12-31 13F LINEAGE CELL THERAPEUTICS IN COM 53566P109 17,179 -5,686 -24.87 15 -40.00 0.0001
2019-08-09 2019-06-30 13F BIOTIME COM 09066L105 22,865 3,010 15.16 25 -3.85 0.0002
2019-05-14 2019-03-31 13F/A-1 BIOTIME COM 09066L105 19,855 18,613 1,498.63 26 2,500.00 0.0003
2019-05-13 2019-03-31 13F BIOTIME COM 09066L105 19,855 18,613 26
2019-02-05 2018-12-31 13F BIOTIME COM 09066L105 1,242 1,242 1 0.0000
2018-05-16 2018-03-31 13F/A-1 BIOTIME COM 09066L105 0 -2,048 -100.00 0 -100.00
2018-02-09 2017-12-31 13F BIOTIME COM 09066L105 2,048 -25,100 -92.46 4 -94.81 0.0000
2017-11-15 2017-09-30 13F BIOTIME COM 09066L105 27,148 -3,334 -10.94 77 -19.79 0.0007
2017-08-14 2017-06-30 13F BIOTIME COM 09066L105 30,482 14,362 89.09 96 71.43 0.0010
2017-05-10 2017-03-31 13F BIOTIME COM 09066L105 16,120 5,678 54.38 56 47.37 0.0007
2017-02-15 2016-12-31 13F BIOTIME COM 09066L105 10,442 10,442 187.74 38 1,166.67 0.0004
2016-11-14 2016-09-30 13F BIOTIME COM 09066L105 0 -6,794 -100.00 0 -100.00
2016-08-12 2016-06-30 13F BIOTIME COM 09066L105 6,794 -17,908 -72.50 18 -74.65 0.0002
2016-05-12 2016-03-31 13F BIOTIME COM 09066L105 24,702 -821 -3.22 71 -32.38 0.0010
2016-02-11 2015-12-31 13F BIOTIME COM 09066L105 25,523 -35,684 -58.30 105 -42.93 0.0012
2015-11-20 2015-09-30 13F/A-1 BIOTIME COM 09066L105 61,207 -3,799 -5.84 184 -22.03 0.0025
2015-11-06 2015-09-30 13F BIOTIME COM 09066L105 61,207 184
2015-08-11 2015-06-30 13F BIOTIME COM 09066L105 65,006 36,205 125.71 236 65.03 0.0033
2015-05-14 2015-03-31 13F BIOTIME COM 09066L105 28,801 -37,174 -56.35 143 -41.87 0.0022
2015-02-11 2014-12-31 13F BIOTIME COM 09066L105 65,975 -3,620 -5.20 246 12.33 0.0037
2014-10-31 2014-09-30 13F BIOTIME COM 09066L105 69,595 52,308 302.59 219 313.21 0.0034
2014-08-12 2014-06-30 13F BIOTIME COM 09066L105 17,287 9,167 112.89 53 96.30 0.0008
2014-05-07 2014-03-31 13F BIOTIME COM 09066L105 8,120 -36,304 -81.72 27 -83.12 0.0005
2014-01-31 2013-12-31 13F BIOTIME COM 09066L105 44,424 30,789 225.81 160 196.30 0.0024
2013-08-02 2013-06-30 13F BIOTIME COM 09066L105 13,635 13,635 54 0.0013
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 44,000 -56.95 73 -57.56 n/a n/a n/a
2025-11-12 2025-09-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 102,200 -63.34 173 -31.75 n/a n/a n/a
2025-08-14 2025-06-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 278,800 55.58 253 215.00 n/a n/a n/a
2025-05-14 2025-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 179,200 245.28 81 207.69 n/a n/a n/a
2025-05-14 2024-12-31 13F/A LINEAGE CELL THERAPEUTICS IN COM Call 51,900 26 n/a n/a n/a
2025-02-14 2024-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 51,900 26 n/a n/a n/a
2024-11-14 2024-09-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 67,500 -53.61 67 -68.84 n/a n/a n/a
2024-05-10 2024-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 145,500 1,234.86 215 1,854.55 n/a n/a n/a
2024-02-14 2023-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 10,900 -54.77 12 -60.71 n/a n/a n/a
2023-11-09 2023-09-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 24,100 -23.49 28 -36.36 n/a n/a n/a
2023-08-09 2023-06-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 31,500 542.86 44 528.57 n/a n/a n/a
2023-05-12 2023-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 4,900 -71.68 7 -65.00 n/a n/a n/a
2023-02-09 2022-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 17,300 -64.11 20 -62.96 n/a n/a n/a
2022-11-09 2022-09-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 48,200 54 n/a n/a n/a
2022-08-11 2022-06-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 70,200 -37.88 108 -61.01 n/a n/a n/a
2022-02-11 2021-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 113,000 89.60 277 84.67 n/a n/a n/a
2021-11-12 2021-09-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 59,600 -19.57 150 -28.91 n/a n/a n/a
2021-08-10 2021-06-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 74,100 -33.12 211 -18.85 n/a n/a n/a
2021-05-12 2021-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 110,800 -41.16 260 -21.45 n/a n/a n/a
2021-02-10 2020-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 188,300 1,155.33 331 2,264.29 n/a n/a n/a
2020-11-12 2020-09-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 15,000 -56.01 14 -53.33 n/a n/a n/a
2020-08-13 2020-06-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 34,100 12.91 30 20.00 n/a n/a n/a
2020-05-13 2020-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 30,200 25 n/a n/a n/a
2020-02-10 2019-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-12 2019-09-30 13F LINEAGE CELL THERAPEUTICS IN COM Call 1,500 114.29 1 0.00 n/a n/a n/a
2019-08-09 2019-06-30 13F BIOTIME COM Call 700 1 n/a n/a n/a
2019-02-05 2018-12-31 13F BIOTIME COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F BIOTIME COM Call 28,800 185.15 68 223.81 n/a n/a n/a
2018-08-13 2018-06-30 13F BIOTIME COM Call 10,100 -88.47 21 -91.10 n/a n/a n/a
2018-05-16 2018-03-31 13F/A BIOTIME COM Call 87,600 236 n/a n/a n/a
2018-05-10 2018-03-31 13F BIOTIME COM Call 87,600 236 n/a n/a n/a
2017-11-14 2017-09-30 13F BIOTIME COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F BIOTIME COM Call 4,200 425.00 13 333.33 n/a n/a n/a
2017-05-10 2017-03-31 13F BIOTIME COM Call 800 -11.11 3 0.00 n/a n/a n/a
2017-02-15 2016-12-31 13F BIOTIME COM Call 900 3 n/a n/a n/a
2016-05-12 2016-03-31 13F BIOTIME COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-11 2015-12-31 13F BIOTIME COM Call 3,400 -87.81 14 -83.33 n/a n/a n/a
2015-11-20 2015-09-30 13F/A BIOTIME COM Call 27,900 -33.41 84 -44.74 n/a n/a n/a
2015-11-06 2015-09-30 13F BIOTIME COM Call 27,900 84 n/a n/a n/a
2015-08-11 2015-06-30 13F BIOTIME COM Call 41,900 19.71 152 -12.64 n/a n/a n/a
2015-05-14 2015-03-31 13F BIOTIME COM Call 35,000 11,566.67 174 17,300.00 n/a n/a n/a
2014-05-07 2014-03-31 13F BIOTIME COM Call 300 -99.29 1 -99.38 n/a n/a n/a
2013-11-15 2013-09-30 13F BIOTIME COM Call 42,400 84.35 161 76.92 n/a n/a n/a
2013-08-02 2013-06-30 13F BIOTIME COM Call 23,000 91 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Put 1,500 3 n/a n/a n/a
2023-11-09 2023-09-30 13F LINEAGE CELL THERAPEUTICS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-09 2023-06-30 13F LINEAGE CELL THERAPEUTICS IN COM Put 2,000 0.00 3 -33.33 n/a n/a n/a
2023-05-12 2023-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Put 2,000 3 n/a n/a n/a
2022-08-11 2022-06-30 13F LINEAGE CELL THERAPEUTICS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Put 2,400 -84.62 4 -89.47 n/a n/a n/a
2022-02-11 2021-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Put 15,600 188.89 38 171.43 n/a n/a n/a
2021-11-12 2021-09-30 13F LINEAGE CELL THERAPEUTICS IN COM Put 5,400 42.11 14 27.27 n/a n/a n/a
2021-08-10 2021-06-30 13F LINEAGE CELL THERAPEUTICS IN COM Put 3,800 -55.81 11 -45.00 n/a n/a n/a
2021-05-12 2021-03-31 13F LINEAGE CELL THERAPEUTICS IN COM Put 8,600 207.14 20 300.00 n/a n/a n/a
2021-02-10 2020-12-31 13F LINEAGE CELL THERAPEUTICS IN COM Put 2,800 -72.00 5 -54.55 n/a n/a n/a
2019-08-09 2019-06-30 13F BIOTIME COM Put 10,000 92.31 11 57.14 n/a n/a n/a
2019-05-14 2019-03-31 13F/A BIOTIME COM Put 5,200 7 n/a n/a n/a
2019-05-13 2019-03-31 13F BIOTIME COM Put 5,200 7 n/a n/a n/a
2018-02-09 2017-12-31 13F BIOTIME COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F BIOTIME COM Put 30,000 5.63 85 -4.49 n/a n/a n/a
2017-08-14 2017-06-30 13F BIOTIME COM Put 28,400 45.64 89 32.84 n/a n/a n/a
2017-05-10 2017-03-31 13F BIOTIME COM Put 19,500 2.63 67 -2.90 n/a n/a n/a
2017-02-15 2016-12-31 13F BIOTIME COM Put 19,000 69 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOTIME COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-12 2016-06-30 13F BIOTIME COM Put 8,000 -82.68 21 -84.21 n/a n/a n/a
2016-05-12 2016-03-31 13F BIOTIME COM Put 46,200 96.60 133 38.54 n/a n/a n/a
2016-02-11 2015-12-31 13F BIOTIME COM Put 23,500 -75.60 96 -66.78 n/a n/a n/a
2015-11-20 2015-09-30 13F/A BIOTIME COM Put 96,300 37.97 289 14.23 n/a n/a n/a
2015-11-06 2015-09-30 13F BIOTIME COM Put 96,300 289 n/a n/a n/a
2015-08-11 2015-06-30 13F BIOTIME COM Put 69,800 48.20 253 8.12 n/a n/a n/a
2015-05-14 2015-03-31 13F BIOTIME COM Put 47,100 -26.98 234 -2.90 n/a n/a n/a
2015-02-11 2014-12-31 13F BIOTIME COM Put 64,500 -26.70 241 -12.68 n/a n/a n/a
2014-10-31 2014-09-30 13F BIOTIME COM Put 88,000 232.08 276 240.74 n/a n/a n/a
2014-08-12 2014-06-30 13F BIOTIME COM Put 26,500 96.30 81 84.09 n/a n/a n/a
2014-05-07 2014-03-31 13F BIOTIME COM Put 13,500 -64.57 44 -67.88 n/a n/a n/a
2014-01-31 2013-12-31 13F BIOTIME COM Put 38,100 102.66 137 92.96 n/a n/a n/a
2013-11-15 2013-09-30 13F BIOTIME COM Put 18,800 -47.63 71 -50.00 n/a n/a n/a
2013-08-02 2013-06-30 13F BIOTIME COM Put 35,900 142 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.